4//SEC Filing
Goldman Steven M. 4
Accession 0001209191-18-046706
CIK 0001685071other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:46 AM ET
Size
8.7 KB
Accession
0001209191-18-046706
Insider Transaction Report
Form 4
Goldman Steven M.
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2018-08-13−1,832→ 20,168 totalExercise: $7.32Exp: 2027-05-24→ Common Stock (1,832 underlying) - Exercise/Conversion
Common Stock
2018-08-13$7.32/sh+1,832$13,410→ 125,001 total
Holdings
- 5,000(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]These shares are held by the Steven M. Goldman Family LLC (the "LLC"), of which the Reporting Person is the Managing Member. The voting and investment decisions of the LLC are made by an independent external asset manager. The Reporting Person disclaims beneficial ownership of the shares held by the LLC except to the extent of his pecuniary interest in the LLC, if any, and the inclusion of these shares on this report shall not be deemed an admission that the Reporting Person beneficially owns the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.
- [F2]The option vests over a period of three years as follows: (i) one-third of the total shares subject to the option shall vested on May 25, 2018, and (ii) 1/36th of total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service with the Issuer on each such date. The option allows for early exercise, subject to the Issuer's repurchase option, with respect to any unvested shares of Common Stock.
Documents
Issuer
Dova Pharmaceuticals, Inc.
CIK 0001685071
Entity typeother
Related Parties
1- filerCIK 0001568216
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 7:46 AM ET
- Size
- 8.7 KB